Role of glycosphingolipids and therapeutic perspectives on Alzheimer's disease
- PMID: 16918389
- DOI: 10.2174/187152706777950710
Role of glycosphingolipids and therapeutic perspectives on Alzheimer's disease
Abstract
Alzheimer's disease (AD) is a devastating neurodegenerative disorder dividing into two forms, early onset familial and late onset sporadic forms. Early onset genetic cases (familial AD (FAD)) constitute about 10% of all AD cases. Heretofore, highly fibrillinogenic and pathological Abeta peptide formation is regarded as the fundamental molecular basis for this disorder. Recent enormous efforts to find out a pathogenesis, however, have revealed that this disorder has a multiplicity of causes such as glycosphingolipids abnormalities, impairment of neurotrophin signaling, protein trafficking, and protein turnover. Most of these aspects were disclosed by the studies on FAD-related presenilin. In this review, we will focus on the current knowledge of many abnormal aspects of cellular lipids, especially glycosphingolipids other than a pathogenic Abeta production caused by the mutant presenilins as a model system. Moreover, we will discuss how these glycosphingolipids abnormalities cause the pathological conditions found in this disorder.
Similar articles
-
[Abnormal connection of mutant PS1 to glycosphingolipids metabolism].Tanpakushitsu Kakusan Koso. 2004 Nov;49(15 Suppl):2473-8. Tanpakushitsu Kakusan Koso. 2004. PMID: 15553004 Review. Japanese. No abstract available.
-
Presenilins and Alzheimer's disease: biological functions and pathogenic mechanisms.Prog Neurobiol. 2000 Mar;60(4):363-84. doi: 10.1016/s0301-0082(99)00033-7. Prog Neurobiol. 2000. PMID: 10670705 Review.
-
APP intracellular domain formation and unaltered signaling in the presence of familial Alzheimer's disease mutations.Exp Cell Res. 2003 Jul 1;287(1):1-9. doi: 10.1016/s0014-4827(03)00117-4. Exp Cell Res. 2003. PMID: 12799176
-
Abeta42, presenilins, and Alzheimer's disease.Neurobiol Aging. 1998 Jan-Feb;19(1 Suppl):S11-3. doi: 10.1016/s0197-4580(98)00027-x. Neurobiol Aging. 1998. PMID: 9562460
-
Familial Alzheimer's disease: oxidative stress, beta-amyloid, presenilins, and cell death.Gen Pharmacol. 1998 Nov;31(5):675-81. doi: 10.1016/s0306-3623(98)00189-x. Gen Pharmacol. 1998. PMID: 9809462 Review.
Cited by
-
The pathological roles of ganglioside metabolism in Alzheimer's disease: effects of gangliosides on neurogenesis.Int J Alzheimers Dis. 2011 Jan 9;2011:193618. doi: 10.4061/2011/193618. Int J Alzheimers Dis. 2011. PMID: 21274438 Free PMC article.
-
Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease--a review.J Lipid Res. 2008 Jun;49(6):1157-75. doi: 10.1194/jlr.R800007-JLR200. Epub 2008 Mar 11. J Lipid Res. 2008. PMID: 18334715 Free PMC article. Review.
-
Evidence that small molecule enhancement of β-hexosaminidase activity corrects the behavioral phenotype in Dutch APP(E693Q) mice through reduction of ganglioside-bound Aβ.Mol Psychiatry. 2015 Feb;20(1):109-17. doi: 10.1038/mp.2014.135. Epub 2014 Oct 28. Mol Psychiatry. 2015. PMID: 25349165 Free PMC article.
-
Ganglioside metabolism in a transgenic mouse model of Alzheimer's disease: expression of Chol-1α antigens in the brain.ASN Neuro. 2010 Oct 4;2(4):e00044. doi: 10.1042/AN20100021. ASN Neuro. 2010. PMID: 20930939 Free PMC article.
-
Omega-3 fatty acids, lipids, and apoE lipidation in Alzheimer's disease: a rationale for multi-nutrient dementia prevention.J Lipid Res. 2017 Nov;58(11):2083-2101. doi: 10.1194/jlr.R076331. Epub 2017 May 20. J Lipid Res. 2017. PMID: 28528321 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical